Everolimus Eg

Everolimus Eg is an oral medication used for various therapeutic purposes. This pharmaceutical is manufactured by Eurogenerics N.V./S.A. and is intended for oral use.

Everolimus Eg is primarily used to support immune system suppression in transplant patients. It helps prevent the body from rejecting transplanted organs by modulating immune responses. Additionally, it may be prescribed for certain types of cancer to inhibit tumor growth and slow disease progression.

Common effects of Everolimus Eg may include fatigue, mouth sores, and swelling in the limbs. Some users might experience changes in appetite or gastrointestinal discomfort. These effects can vary widely among individuals and are not exhaustive.

Everolimus Eg should be handled with care, especially by those with pre-existing liver or kidney conditions. Regular monitoring by a healthcare provider is recommended. It is important to follow the prescribed regimen and report any unusual symptoms promptly.

Everolimus Eg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and other immunosuppressive drugs can also affect its efficacy and safety. Always consult a healthcare provider before combining medications.